Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBT (2016 - 2026)

Neogen has reported EBT over the past 17 years, most recently at -$20.3 million for Q1 2026.

  • Quarterly results put EBT at -$20.3 million for Q1 2026, down 109.28% from a year ago — trailing twelve months through Feb 2026 was -$628.1 million (down 23.57% YoY), and the annual figure for FY2025 was -$1.1 billion, down 7821.08%.
  • EBT for Q1 2026 was -$20.3 million at Neogen, roughly flat from -$20.4 million in the prior quarter.
  • Over the last five years, EBT for NEOG hit a ceiling of $43.8 million in Q3 2025 and a floor of -$631.2 million in Q2 2025.
  • Median EBT over the past 5 years was -$5.8 million (2024), compared with a mean of -$67.1 million.
  • Biggest five-year swings in EBT: tumbled 12618.76% in 2024 and later skyrocketed 380.66% in 2025.
  • Neogen's EBT stood at -$34.1 million in 2022, then skyrocketed by 89.01% to -$3.7 million in 2023, then tumbled by 12618.76% to -$476.6 million in 2024, then skyrocketed by 95.73% to -$20.4 million in 2025, then grew by 0.31% to -$20.3 million in 2026.
  • The last three reported values for EBT were -$20.3 million (Q1 2026), -$20.4 million (Q4 2025), and $43.8 million (Q3 2025) per Business Quant data.